News

Published on 12 Nov 2021 on Benzinga via Yahoo Finance

The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled...

Article preview image

Here's a roundup of top developments in the biotech space over the last 24 hours.

Stocks In Focus J&J to Separate Its Consumer Health Business Into a New Publicly Traded Company

Read the rest of the article
NASDAQ.ONCS price evolution
NASDAQ.ITRM price evolution
NASDAQ.THMO price evolution
MIL.NEXI price evolution
NASDAQ.AZN price evolution
LSE.AZN price evolution
NASDAQ.BIIB price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
US biopharma first quarter earnings seen stable amid low expectations

Expectations for US biopharma companies' first quarter earnings are low given the typical...

Proactive Investors 12 Apr 2024
GLP-1s benefit Parkinson’s: Barclays sees biopharma impact

Barclays cites implications for the biopharma sector after a mid-stage trial showed that the GLP-...

Seeking Alpha 12 Apr 2024
ALX Oncology (ALXO) Posts Upbeat Results From Lymphoma Study

ALX Oncology Holdings Inc. ALXO reported positive results from an ongoing phase I/II investigator...

Zacks via Yahoo Finance 11 Apr 2024
12 Best Depressed Stocks To Buy in 2024

In this article, we will take a detailed look at the 12 Best Depressed Stocks To Buy in 2024. For...

Insider Monkey via Yahoo Finance 10 Apr 2024
Thermo Fisher CEO's compensation dropped by 33% last year - Boston Business Journal

In 2022, Casper's pay package was the fourth-highest in Massachusetts for a CEO of a public compa...

The Business Journals 9 Apr 2024
Phathom Pharma, Rhythm, Vaxcyte most likely takeover targets in pharma - analyst

Phantom Pharmaceuticals, Rhythm Pharmaceuticals, and Vaxcyte are top takeover candidates in the...

Seeking Alpha 7 Apr 2024
Biotech ripe for ‘cascade of dealmaking’ - Here are the top companies to watch By Investing.com

Few corners of the market have been as prone to dealmaking over the last couple of years as the l...

Investing.com 5 Apr 2024
InMed reports progress in Alzheimer's treatment studies By Investing.com

InMed Pharmaceuticals Inc. (NASDAQ: INM), a company specializing in rare cannabinoids and...

Investing.com 4 Apr 2024
Biogen's head of development sells shares worth over $19k

In a recent transaction, Priya Singhal, Head of Development at Biogen Inc. (NASDAQ: BIIB ), sold ...

Investing.com 4 Apr 2024
InMed reports progress in Alzheimer's treatment studies

InMed Pharmaceuticals Inc. ( NASDAQ : INM), a company specializing in rare cannabinoids and...

Investing.com 4 Apr 2024

Copyright Statfolio @ 2024

Social Accounts